EUVIMEDEUVIMED entdecken
Crossref

Trends in Reflexive Hepatitis C Virus Testing in a National US Laboratory: A Retrospective Study From 2018 to 2024

Min Kyung Lee, David Alfego iD, Charles Walworth, Laura Gillim iD

Clinical Infectious Diseases · 2026

DOI: 10.1093/cid/ciag227 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2026. Verfasst von Min Kyung Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Diagnostics, Labcorp, Burlington, North Carolina, USA. Hauptthemen laut MEDLINE: Hepatitis C, Hepacivirus, Mass Screening. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Labcorp.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In 2019 and 2020, universal hepatitis C screening of adults was recommended by clinical guideline authorities, including the Centers for Disease Control and Prevention (CDC). In 2023, CDC recommendations emphasized the importance of reflexive hepatitis C testing in which samples positive for hepatitis C virus (HCV) antibody (Ab) automatically reflex to viral RNA nucleic acid amplification testing (NAAT). Laboratory stewardship initiatives to guide compliance with expanded guidelines were implemented.

Methods

We conducted a retrospective review of 38 233 788 specimens with HCV Ab testing and 1 423 543 follow-up HCV RNA NAAT performed from 2018 to 2024 to evaluate the impact of expanded hepatitis C guidelines and laboratory stewardship initiatives.

Results

From 2018 to 2024, reflexive hepatitis C testing volumes increased annually, while orders for standalone HCV Ab testing and HCV Ab positivity rates steadily declined. Among HCV Ab–positive individuals, the percentage with reflexive testing increased from 21.9% in 2018 to 82.2% in 2024 (Ƭ = 1.00, P = .003) and RNA testing rates increased from 66.4% in 2018 to 89.3% in 2024 (Ƭ = 1.00, P = .003). Follow-up RNA testing was increasingly completed earlier in HCV Ab–positive individuals with the same-day RNA testing rate increasing from 38.0% in 2018 to 82.2% in 2024. HCV RNA positivity decreased 19.2% during the study period.

Conclusions

Expanded hepatitis C screening guidelines highlighting the importance of reflexive HCV testing and subsequent internal laboratory stewardship initiatives likely contributed to the increased utilization of reflexive hepatitis C testing and the decreased time to identification of active hepatitis C infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis CHepacivirusMass ScreeningHumansRetrospective StudiesUnited StatesHepatitis C AntibodiesRNA, ViralNucleic Acid Amplification TechniquesCenters for Disease Control and Prevention, U.S.

Stichwörter der Autor:innen

and HCV antibody testinghepatitis C virus (HCV)reflexive HCV testinguniversal HCV screening

Substanzen

Hepatitis C AntibodiesRNA, Viral

Autor:innen und Institutionen

  • Diagnostics, Labcorp, Burlington, North Carolina, USA.

ORCID-Profile: David Alfego, Laura Gillim

Förderung

  • Labcorp

Zitieren

APA

Lee, M. K., Alfego, D., Walworth, C., & Gillim, L. (2026). Trends in Reflexive Hepatitis C Virus Testing in a National US Laboratory: A Retrospective Study From 2018 to 2024. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciag227

Vancouver

Lee MK, Alfego D, Walworth C, Gillim L. Trends in Reflexive Hepatitis C Virus Testing in a National US Laboratory: A Retrospective Study From 2018 to 2024. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciag227

BibTeX
@article{Lee2026,
  author = {Lee, Min Kyung and Alfego, David and Walworth, Charles and Gillim, Laura},
  title = {Trends in Reflexive Hepatitis C Virus Testing in a National US Laboratory: A Retrospective Study From 2018 to 2024},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  doi = {10.1093/cid/ciag227}
}
Kostenlos starten →